Combination of hormonal-based therapy in endometrial cancer: ready for prime time
Int J Gynecol Cancer
.
2023 Nov 6;33(11):1682-1683.
doi: 10.1136/ijgc-2023-005031.
Authors
María Clara Santía
1
,
José C Vilches
2
,
Pedro T Ramirez
3
Affiliations
1
Obstetrics and Gynecology, Houston Methodist Hospital, Houston, Texas, USA
[email protected]
.
2
Obstetrics and Gynecology, Hospital Quiron Salud Malaga, Malaga, Spain.
3
Obstetrics and Gynecology, Houston Methodist Hospital, Houston, Texas, USA.
PMID:
37875324
DOI:
10.1136/ijgc-2023-005031
No abstract available
Keywords:
Uterine Cancer.
Publication types
Editorial
MeSH terms
Endometrial Neoplasms*
Female
Humans
Medroxyprogesterone Acetate
Substances
Medroxyprogesterone Acetate